RALEIGH, N.C.--(BUSINESS WIRE)-- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) on March 7, 2011 for ...
LAVAL, Quebec, May 27, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received ...
RALEIGH, N.C., Feb 23, 2010 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/comstock/15*!slxp/quotes/nls/slxp (SLXP 28.40, +4.15, +17.11%) today reported that ...
RALEIGH, N.C.-- (BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the topline results from the analysis of the microbiome, culture and susceptibility, and two key secondary ...
Bausch Health, its Salix business unit, and Salix’s licensor Alfasigma, have agreed to resolve outstanding intellectual property disputes with Sun Pharmaceuticals regarding Xifaxan (rifaximin) 200-mg ...
LAVAL, Quebec, May 6, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), ...
Bausch Health, and its gastroenterology business Salix Pharmaceuticals, announced that the U.S. Court of Appeals for the Federal Circuit in the matter of Salix Pharmaceuticals, LTD. et al v. Norwich ...
BRIDGEWATER, N.J., Oct. 1, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), ...
BRIDGEWATER, N.J., Oct. 1, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results